PQQ

PQQ

PQQ (pyrroloquinoline quinone) is a small redox-active molecule that helps your cells build and protect their mitochondria, the structures that make energy. Most people take it for the same reason they take CoQ10: better daytime energy, less mental fog, and feeling less worn down. The difference is that CoQ10 supports the mitochondria you already have, while PQQ pushes your cells to make more of them.
Practically, it's most relevant if you're in your 30s or older and noticing your baseline energy or mental sharpness slipping, if you train hard and want better recovery, or if you're stacking it with CoQ10 as a long-term mitochondrial support. Effects build over weeks, not hours. It's not a stimulant, so don't expect a hit.

Deep-dive

PQQ was first identified in 1979 as a bacterial enzyme cofactor. It's found naturally in small amounts in foods like fermented soy (natto), parsley, kiwi, green peppers, cocoa, and human breast milk, but supplemental doses are roughly 250 times higher than what you'd get from food.
How it actually works. The headline mechanism is mitochondrial biogenesis, meaning it stimulates cells to grow new mitochondria. PQQ does this by phosphorylating CREB and upregulating PGC-1α, the master regulator of mitochondrial production, which then activates downstream factors (NRF-1, NRF-2, TFAM) that build new mitochondria. This was first shown in Chowanadisai's 2010 work and has since been replicated in multiple cell and animal models, including via AMPK activation and SIRT1/PGC-1α signaling.
PQQ is also a genuinely potent antioxidant. Unlike most antioxidants which get used up after one reaction, PQQ can cycle through thousands of redox reactions before degrading. It scavenges reactive oxygen species directly and reduces lipid peroxidation, which a 2013 human crossover study by Harris et al. confirmed via decreased TBARS markers after a single dose.
Inflammation and metabolic markers. The same Harris study found that 0.3 mg/kg/day for three days significantly reduced plasma C-reactive protein (CRP) and interleukin-6 (IL-6), both standard markers of systemic inflammation, alongside reductions in urinary trimethylamine N-oxide (TMAO), a gut-derived metabolite linked to cardiovascular and renal risk. These are early signals from a small (n=10) uncontrolled study, but they're consistent with the mitochondrial and antioxidant mechanisms.
Cognition. Three placebo-controlled human trials are worth knowing. Nakano et al. (2016) gave 41 elderly adults 20 mg/day of PQQ for 12 weeks and found improved Stroop test performance (selective attention) and increased prefrontal cortex blood flow on near-infrared spectroscopy. Tamakoshi et al. (2023) tested 20 mg/day in adults aged 20-65 and found different patterns by age: younger adults (20-40) showed faster gains in cognitive flexibility and processing speed by week 8, while older adults (41-65) saw memory improvements by week 12. A more recent 2024 trial in elderly with mild cognitive impairment using a hydrogen-PQQ combination showed elevated serum BDNF, improved cerebral oxygenation, and gains in mental orientation, though the hydrogen component complicates interpretation.
Note that most of these trials are small (n=20-65) and several were funded by the BioPQQ manufacturer. The signal is consistent but the evidence base is thin compared to compounds like creatine.
Exercise and physical performance. Less convincing on this front. A 2020 trial at Baylor gave untrained men 20 mg/day of PQQ alongside six weeks of endurance training. PQQ did increase PGC-1α protein levels significantly compared to placebo, confirming the mitochondrial biogenesis mechanism in humans, but VO2 peak and exercise duration improved equally in both groups. So you get the molecular signal without a clear performance edge.
Women specifically. Most clinical work has either been mixed-sex or specifically included women (the Nakano elderly trial was 28 women out of 41, the Tamakoshi trial was balanced, and the Harris inflammation study was 5 women, 5 men). There's no evidence of meaningful sex differences in cognitive or anti-inflammatory response.
For reproductive aging specifically, all current data is preclinical. Mouse studies show PQQ supplementation preserves ovarian follicle counts, AMH levels, and fertility against chemotherapy-induced ovarian damage, working through reduced granulosa cell oxidative stress and apoptosis. A 2024 study showed PQQ enhances mitochondrial function in human ovarian cells via SIRT1/PGC-1α. This is mechanistically interesting given that egg quality is heavily mitochondria-dependent and declines with age, but no human fertility trials exist yet. Researchers have also flagged a theoretical concern: since PQQ protects all cells from oxidative stress, including potentially cancer cells, women undergoing or recently treated for cancer should not use PQQ for fertility preservation without oncology input.
Limitations of the evidence. Most positive cognitive trials come from a single Japanese research group and were funded by Mitsubishi Gas Chemical, the manufacturer of BioPQQ. Sample sizes are small, placebo controls are sometimes absent (Harris 2013 was uncontrolled), and independent replication is limited. The mitochondrial biogenesis mechanism is well established at the cell and animal level but the leap to subjective energy or performance benefits in healthy humans is not strongly supported by controlled trials. Treat PQQ as plausible and low-risk rather than proven.

Dosage:

  • Standard daily dose: 10-20 mg per day, with 20 mg/day being the dose used in virtually every cognition, sleep, and inflammation trial. This is also the EFSA-approved upper limit for food supplements
  • Timing: Take it in the morning with or without food. PQQ is water-soluble and doesn't need fat for absorption. Peak plasma levels hit around 2-3 hours, half-life is roughly 3-5 hours, so once-daily dosing is fine
  • How long until it works: Effects on cognition, sleep, and inflammation typically take 4-12 weeks to show. Commit to at least 8 weeks before judging it. If you're younger (20s-30s), expect cognitive flexibility and processing speed gains around week 8. If you're older (45+), memory improvements tend to need the full 12 weeks at 20 mg/day
  • Stacking: Pairs naturally with CoQ10 (100-300 mg) for combined mitochondrial support. The two trials testing PQQ + CoQ10 found additive effects on memory in adults 45+. The two work on different parts of the same system, PQQ builds mitochondria, CoQ10 helps the existing ones run
  • For women in their late 30s to mid-40s thinking about egg quality, PQQ is often stacked with CoQ10 (100-300 mg) starting 3-4 months before any conception attempt, since that's the egg maturation window. This protocol is mechanism-based, not trial-proven
  • Don't push higher. The EFSA NOAEL is 100 mg/kg in animals, but renal toxicity (urinary crystals and protein) appeared at 200 mg/kg in rats. There's no reason to go past 20-40 mg/day in humans, and no clinical evidence higher doses do more
  • Pregnancy and breastfeeding: skip it. EFSA explicitly excluded this group from its safety assessment

Here's what you can expect:

Most people don't feel anything in the first few days. The honest expectation is a gradual lift in baseline energy, less of an afternoon crash, and slightly clearer thinking after 4-8 weeks. Some people report better sleep quality, particularly falling asleep faster and feeling more rested, which showed up in the Japanese open-label sleep trial.
If you're younger (20s-30s), the more noticeable effects tend to be on mental sharpness and processing speed. If you're older (45+), it's more likely to show up as memory improvements that build over 12 weeks. If you train hard, expect better recovery and potentially less inflammation, but don't expect a clear performance bump.
If you feel nothing after 12 weeks at 20 mg/day, it's probably not doing much for you and you can stop without any taper.

Side effects & risks:

  • Generally very well tolerated. Across all human trials at 20 mg/day, no serious adverse events have been reported, no abnormal blood or urine findings, and no liver or kidney issues. The EFSA safety review (2017) approved it as a novel food at up to 20 mg/day for healthy adults
  • Kidney stress at very high doses. In animals, 200 mg/kg+ caused urinary protein and crystals. Not relevant at human supplemental doses but a reason not to mega-dose
  • Headache, mild nausea, and fatigue have been anecdotally reported at higher doses (40+ mg) but aren't documented in trials
  • Pregnancy and breastfeeding: specifically excluded from safety assessments. Avoid until human pregnancy data exists
  • No documented drug interactions, but the human research base is small enough that interactions may simply not have been identified yet
  • Active or recent cancer: theoretical concern given PQQ's broad cytoprotective effects. Not a proven risk but worth flagging if you're in or recently out of cancer treatment, or considering it for fertility preservation around chemotherapy
🩸

Blood markers

hs-CRP (and optionally IL-6), baseline before starting. This is the most reproducible human signal for PQQ. If your baseline inflammation is already low, there's not much for it to lower.
Creatinine and urinalysis (eGFR), baseline only if you have a history of kidney issues, given the high-dose animal renal findings. Standard supplemental doses (20 mg/day) haven't shown kidney effects in humans, but a baseline gives you a reference point.
Recheck hs-CRP at 8-12 weeks. A meaningful drop suggests it's doing something useful for you systemically. For cognitive effects, subjective tracking (energy, focus, sleep quality) is more practical than any blood marker, since BDNF and brain metabolism markers aren't routinely available.
Who actually needs what: healthy adults under 40 with no inflammation issues probably don't need any monitoring. Adults over 45, anyone with elevated baseline inflammation, and anyone using PQQ alongside other mitochondrial supplements (CoQ10, NMN, urolithin A) should track hs-CRP at minimum. Anyone with existing kidney disease should not start PQQ without their physician's input and a baseline urinalysis and eGFR.
Sold as a dietary supplement in most countries without prescription.